OMGA News and Press, Omega Therapeutics Inc. From 01/04/24

2024-01-04 10:00:42 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Omega Therapeutics Inc (NASDAQ: OMGA), Avenue Therapeutics Inc (NASDAQ: ATXI), Rapid Micro Biosystems Inc (NAS...

2024-01-04 10:00:14 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

2024-01-04 07:23:57 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- Omega Therapeutics, Inc. (NASDAQ: OMGA) announced, this morning, along with Novo Nordisk and Cellarity Inc. that Novo Nordisk entered into separate research collaborations with each company, with the...

2024-01-04 06:26:58 ET Danish drugmaker Novo Nordisk ( NVO ) announced on Thursday research collaborations with two U.S. biotech firms to discover and develop novel treatment approaches for cardiometabolic diseases. The collaborations with Omega Therapeutics ( NASDAQ: OMGA )...

CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced that management will present at the...

2023-12-06 16:37:38 ET Verint Systems  ( VRNT ) +11% . ZyVersa Therapeutics ( ZVSA ) +6% . Couchbase ( BASE ) +4% . Grayscale Solana Trust  ( OTCQB:GSOL ) +4% . Cabaletta  ( CABA ) +3% . Vivid Seats ( SEAT ) ...

CAMBRIDGE, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced that management will participate in a fi...

Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics PR Newswire Quotient's Somatic Genomics platform reveals new approaches to treat disease based on the vast genetic variation present in the body's trilli...

CAMBRIDGE, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced that management will participate in a fi...

First-ever demonstration of sustained pre-transcriptional upregulation of gene expression by an epigenomic controller in both in vitro and in vivo models of liver fibrosis Single epigenomic controller demonstrated ability to simultaneously regulate the expression of chemokines CXCL9-11 ...